Tessier-Lavigne Marc 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Oct 3, 2022
Insider Transaction Report
Form 4
Tessier-Lavigne Marc
Director
Transactions
- Sale
Common Stock
2022-09-29$689.56/sh−1,009$695,766→ 4,084 total - Exercise/Conversion
Common Stock
2022-09-30$413.33/sh+3,428$1,416,895→ 5,697 total - Exercise/Conversion
Common Stock
2022-09-29$413.33/sh+3,798$1,569,827→ 6,067 total - Sale
Common Stock
2022-09-29$687.90/sh−321$220,816→ 5,730 total - Sale
Common Stock
2022-09-29$696.13/sh−85$59,171→ 2,753 total - Sale
Common Stock
2022-09-29$697.29/sh−160$111,566→ 2,593 total - Sale
Common Stock
2022-09-29$686.89/sh−16$10,990→ 6,051 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2022-10-03−3,612→ 0 totalExercise: $413.33Exp: 2025-01-02→ Common Stock (3,612 underlying) - Sale
Common Stock
2022-09-29$688.71/sh−637$438,708→ 5,093 total - Sale
Common Stock
2022-09-29$690.65/sh−692$477,930→ 3,392 total - Sale
Common Stock
2022-09-29$691.59/sh−554$383,141→ 2,838 total - Sale
Common Stock
2022-09-29$699.82/sh−80$55,986→ 2,305 total - Sale
Common Stock
2022-09-29$702.36/sh−16$11,238→ 2,289 total - Sale
Common Stock
2022-09-29$698.44/sh−208$145,276→ 2,385 total - Sale
Common Stock
2022-09-30$698.00/sh−3,428$2,392,744→ 2,269 total - Exercise/Conversion
Common Stock
2022-10-03$413.33/sh+3,612$1,492,948→ 5,881 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2022-09-29−3,798→ 7,040 totalExercise: $413.33Exp: 2025-01-02→ Common Stock (3,798 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2022-09-30−3,428→ 3,612 totalExercise: $413.33Exp: 2025-01-02→ Common Stock (3,428 underlying) - Sale
Common Stock
2022-09-29$704.83/sh−20$14,097→ 2,269 total - Sale
Common Stock
2022-10-03$718.00/sh−3,612$2,593,416→ 2,269 total
Footnotes (11)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- [F10]Represents volume-weighted average price of sales of 208 shares of Company stock on September 29, 2022 at prices ranging from $698.19 to $698.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
- [F11]The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
- [F2]Represents volume-weighted average price of sales of 16 shares of Company stock on September 29, 2022 at prices ranging from $686.89 to $686.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
- [F3]Represents volume-weighted average price of sales of 321 shares of Company stock on September 29, 2022 at prices ranging from $687.05 to $687.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
- [F4]Represents volume-weighted average price of sales of 637 shares of Company stock on September 29, 2022 at prices ranging from $688.08 to $688.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
- [F5]Represents volume-weighted average price of sales of 1,009 shares of Company stock on September 29, 2022 at prices ranging from $689.07 to $689.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
- [F6]Represents volume-weighted average price of sales of 692 shares of Company stock on September 29, 2022 at prices ranging from $690.06 to $690.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
- [F7]Represents volume-weighted average price of sales of 554 shares of Company stock on September 29, 2022 at prices ranging from $691.29 to $691.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
- [F8]Represents volume-weighted average price of sales of 85 shares of Company stock on September 29, 2022 at prices ranging from $696.03 to $696.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.
- [F9]Represents volume-weighted average price of sales of 160 shares of Company stock on September 29, 2022 at prices ranging from $697.10 to $697.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 29, 2022 at each separate price.